Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology

Methods in Molecular Biology

Volumn 471, Issue , 2009, Pages 305-333

  Jiang, Jun ^a   Zhang, Xiuqing ^a   Yang, Huanming ^a   Wang, Wendy ^b  

^a Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

ADPRT; Cancer; DNA base excision repair; Genetic epidemiology; Polymorphisms; XPD; XRCC1

Indexed keywords

DNA BINDING PROTEIN; ERCC2 PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, HUMAN; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XRCC1 PROTEIN;

CASE CONTROL STUDY; DNA REPAIR; EPIDEMIOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; NEOPLASM; REVIEW;

CASE-CONTROL STUDIES; DNA REPAIR; DNA-BINDING PROTEINS; EPIDEMIOLOGY, MOLECULAR; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; POLYMORPHISM, GENETIC; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 60349127321     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-416-2_16     Document Type: Review

References (54)

1. Vispe S, Yung TM, Ritchot J, Serizawa H, Satoh MS. (2000) A cellular defense pathway regulating transcription through poly(ADP-ribosyl)ation in response to DNA damage. Proc Natl Acad Sci USA 97(18), 9886-91.
2. Cairns J. (1982) Aging and cancer as genetic phenomena. Natl Cancer Inst Monogr 60, 237-9.
3. Knudson AG Jr. (1989) The genetic predisposition to cancer. Birth Defects Orig Artic Ser 25(2), 15-27. Review
4. Shields PG, Harris CC. (1991) Molecular epidemiology and the genetics of environmental cancer. JAMA 266(5), 681-7. Review.
5. Goode EL, Ulrich CM, Potter JD. (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11(12), 1513-30. Review. Erratum in: Cancer Epidemiol Biomarkers Prev. 2003 Oct; 12(10), 1119.
6. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. (2001) Science 291(5507), 1284-9.
7. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. (2002) Mediation of poly(ADP-ribose) polymerase-1- dependent cell death by apoptosis-inducing factor. Science 297(5579), 259-63.
8. Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ. (2004) The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 64(17), 6344-8.
9. Zhang X, Miao X, Liang G, Hao B, Wang Y, Tan W, Li Y, Guo Y, He F, Wei Q, Lin D. (2005) Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 65(3), 722-6.
10. Hao B, Wang H, Zhou K, Li Y, Chen X, Zhou G, Zhu Y, Miao X, Tan W, Wei Q, Lin D, He F. (2004) Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res. 64(12), 4378-84.
11. Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M. (2006) Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 15(2), 353-8.
12. Gu J, Spitz MR, Yang F, Wu X. (1999) Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk. Carcinogenesis 20(8), 1465-9.
13. Hecht SS. (1999) Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91, 1194-210.
14. Hu Z, Ma H, Lu D, Zhou J, Chen Y, Xu L, Zhu J, Huo X, Qian J, Wei Q, Shen H. (2005) A promoter polymorphism (-77T>C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking. Pharmacogenet Genomics 15(7), 457-63.
15. Tae K, Lee HS, Park BJ, Park CW, Kim KR, Cho HY, Kim LH, Park BL, Shin HD. (2004) Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int J Cancer 111(5), 805-8.
16. Chen S, Tang D, Xue K, Xu L, Ma G, Hsu Y, Cho SS. (2002) DNA repair gene XRCC1 and XPD polymorphisms and risk of lung cancer in a Chinese population. Carcinogenesis 23(8), 1321-5.
17. David-Beabes GL, London SJ. (2001) Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer. 34(3), 333-9.
18. Abdel-Rahman SZ, Soliman AS, Bondy ML, Omar S, El-Badawy SA, Khaled HM, Seifeldin IA, Levin B. (2000) Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 159(1), 79-86.
19. Kietthubthew S, Sriplung H, Au WW, Ishida T. (2006) Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 209(1), 21-9.
20. Chacko P, Rajan B, Joseph T, Mathew BS, Pillai MR. (2005) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 89(1), 15-21.
21. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27(3), 560-7.
22. Duarte MC, Colombo J, Rossit AR, Caetano A, Borim AA, Wornrath D, Silva AE. (2005) Polymorphisms of DNA repair genes XRCC1 and XRCC3, interaction with environmental exposure and risk of chronic gastritis and gastric cancer. World J Gastroenterol 11(42), 6593-600.
23. Chan EC, Lam SY, Fu KH, Kwong YL. (2005) Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet 162(1), 10-20.
24. Hong YC, Lee KH, Kim WC, Choi SK, Woo ZH, Shin SK, Kim H. (2005) Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Int J Cancer 116(3), 428-32.
25. Cao Y, Miao XP, Huang MY, Deng L, Hu LF, Ernberg I, Zeng YX, Lin DX, Shao JY. (2006) Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer 6, 167.
26. Smedby KE, Lindgren CM, Hjalgrim H, Humphreys K, Schollkopf C, Chang ET, Roos G, Ryder LP, Falk KI, Palmgren J, Kere J, Melbye M, Glimelius B, Adami HO. (2006) Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev 15(2), 258-65.
27. Huang WY, Chow WH, Rothman N, Lissowska J, Llaca V, Yeager M, Zatonski W, Hayes RB. (2005) Selected DNA repair polymorphisms and gastric cancer in Poland. Carcinogenesis 26(8), 1354-9.
28. Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W. (2003) A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12(12), 1462-7.
29. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT. (2002) A population-based study of the Arg399Gln polymorphism in X-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma. Cancer Res 62(16), 4630-6.
30. Chen L, Ambrosone CB, Lee J, Sellers TA, Pow-Sang J, Park JY. (2006) Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans. J Urol. 175(1), 108-12; discussion 112.
31. Niwa Y, Matsuo K, Ito H, Hirose K, Tajima K, Nakanishi T, Nawa A, Kuzuya K, Tamakoshi A, Hamajima N. (2005) Association of XRCC1 Arg399Gln and OGG1 Ser-326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. Gynecol Oncol 99(1), 43-9.
32. Jeon YT, Kim JW, Park NH, Song YS, Kang SB, Lee HP. (2005) DNA repair gene XRCC1 Arg399Gln polymorphism is associated with increased risk of uterine leiomyoma. Hum Reprod 20(6), 1586-9. Epub 2005 Mar 10.
33. Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, Kim CH, Park JH, Kam S, Kim IS, Jung TH. (2002) Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 11(1), 23-7.
34. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL. (2005) Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 5, 12.
35. Yin J, Li J, Ma Y, Guo L, Wang H, Vogel U. (2005) The DNA repair gene ERCC2/XPD polymorphism Arg 156Arg (A22541C) and risk of lung cancer in a Chinese population. Cancer Lett 223(2), 219-26.
36. Ketelslegers HB, Gottschalk RW, Godschalk RW, Knaapen AM, van Schooten FJ, Vlietinck RF, Kleinjans JC, van Delft JH. (2006) Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers. Cancer Epidemiol Biomarkers Prev 15(4), 624-9.
37. Vogel U, Olsen A, Wallin H, Overvad K, Tjonneland A, Nexo BA. (2005) Effect of polymorphisms in XPD, RAI, ASE-1 and ERCC1 on the risk of basal cell carcinoma among Caucasians after age 50. Cancer Detect Prev 29(3), 209-14.
38. Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, He X, Bonner MR, Tian L, Yeager M, Welch R, Chanock S, Zheng T, Caporaso N, Lan Q. (2005) Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer 116(5), 768-73.
39. Kietthubthew S, Sriplung H, Au WW, Ishida T. (2006) Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 209(1), 21-9.
40. Vidal AE, Boiteux S, Hickson ID, Radicella JP. (2001) XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 20(22), 6530-9.
41. Hu Z, Ma H, Chen F, Wei Q, Shen H. (2005) XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 14, 1810-8.
42. Ioannidis JP, Ntzani EE, Trikalinos TA. (2004) 'Racial' differences in genetic effects for complex diseases. Nat Genet 36(12), 1312-8.
43. Vineis, P. (1997) Molecular epidemiology: low-dose carcinogens and genetic susceptibility. Int J Cancer 71(1), 1-3.
44. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K. (1991) Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res 51(19), 5177-80.
45. Tiscornia OM, Cresta MA, de Lehmann ES, Belardi G, Dreiling DA. (1986) Estrogen effects on exocrine pancreatic secretion in menopausal women: a hypothesis for menopause-induced chronic pancreatitis. Mt Sinai J Med 53(5), 356-60.
46. Tiscornia OM, Cresta MA, de Lehmann ES, Celener D, Dreiling DA. (1986) Effects of sex and age on pancreatic secretion. Int J Pancreatol 1(2), 95-118.
47. Burcham PC. (1999) Internal hazards: baseline DNA damage by endogenous products of normal metabolism. Mutat Res 443(1-2), 11-36.
48. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, Spitz MR. (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 92(21), 1764-72.
49. Dybdahl M, Vogel U, Frentz G, Wallin H, Nexo BA. (1999) Polymorphisms in the DNA repair gene XPD: correlations with risk and age at onset of basal cell carcinoma. Cancer Epidemiol Biomarkers Prev 8(1), 77-81.
50. Vogel U, Hedayati M, Dybdahl M, Grossman L, and Nexo BA. (2001) Polymorphisms of the DNA repair gene XPD: correlations with risk of basal cell carcinoma revisited. Carcinogenesis 22(6), 899-904. Erratum in: Carcinogenesis 2002 Feb; 23(2), 373.
51. Vogel U, Laros I, Jacobsen NR, Thomsen BL, Bak H,Olsen A,Bukowy Z,Wallin H, Overvad K, Tjonneland A, Nexo BA, Raaschou-Nielsen O. (2004) Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer. Mutat Res 546 (1-2), 65-74.
52. Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. (2002) Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer. Cancer Res 62(5), 1377-81.
53. Hou SM, Falt S, Angelini S, Yang K, Nyberg F, Lambert B, and Hemminki K. (2002) The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 23(4), 599-603.
54. Au WW, Salama SA. (2005) Use of biomarkers to elucidate genetic susceptibility to cancer. Environ Mol Mutagen 45(2-3), 222-8. Review.